Research map: Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma

Back to the article

Papers in this map

  1. Sorafenib in Advanced Hepatocellular Carcinoma · Josep Maria Llovet · 2008 · 13127 citations · Cited by this paper
  2. Comparative evaluation of TACE-RFA versus monotherapies on a background of systemic therapy for recurrent hepatocellular carcinoma: a propensity score-matched analysis · Wendi Zhang · 2026 · Cites this paper
  3. Considerations in Genomic Therapy Matching—Reply · 2026 · Related
  4. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival · Josep Maria Llovet · 2003 · 3040 citations · Cited by this paper
  5. Survival Language · 2026 · Related
  6. Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study · Johannes Lämmer · 2009 · 1566 citations · Cited by this paper
  7. A Dermatologist’s Perspective on Cutaneous Adverse Effects in CTCAE Version 6.0 · 2026 · Related
  8. Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma · on behalf of the PRECISION ITALIA STUDY GROUP · 2014 · 612 citations · Cited by this paper
  9. Global Consensus on the Management of Primary Localized Chordoma · 2026 · Related
  10. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma · Korean Liver Cancer Association (KLCA) · 2022 · 344 citations · Cited by this paper
  11. Survival in the SONIA Trial—Reply · 2026 · Related
  12. CONSORT 2025 Statement · Sally Hopewell · 2025 · 344 citations · Cited by this paper
  13. When TNM Staging Is Not Sufficient · 2026 · Related
  14. Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances · Aaron Michael Orkin · 2021 · 320 citations · Cited by this paper
  15. Treatment Delays in Early Age–Onset Colorectal Cancer · 2026 · Related
  16. Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study · Masatoshi Kudo · 2025 · 319 citations · Cited by this paper
  17. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial · Naïk Vietti Violi · 2018 · 303 citations · Cited by this paper
  18. Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study · Bruno Sangro · 2025 · 294 citations · Cited by this paper
  19. Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial · Jie Yu · 2016 · 204 citations · Cited by this paper
  20. Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma · Dan Su · 2021 · 201 citations · Cited by this paper
  21. BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update · María Reig · 2025 · 194 citations · Cited by this paper
  22. Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009) · Shigeki Arii · 2010 · 164 citations · Cited by this paper
  23. Percutaneous radiofrequency versus microwave ablation for management of hepatocellular carcinoma: a randomized controlled trial · Ahmed Kamal · 2019 · 115 citations · Cited by this paper
  24. Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial · Masafumi Ikeda · 2017 · 92 citations · Cited by this paper
  25. Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians · Dimitrios Moris · 2025 · 80 citations · Cited by this paper
  26. Prospective double-blinded randomized controlled trial of Microwave versus RadioFrequency Ablation for hepatocellular carcinoma (McRFA trial) · Charing C. N. Chong · 2020 · 74 citations · Cited by this paper
  27. Prospective Evaluation of Transcatheter Arterial Chemoembolization (TACE) with Multiple Anti-Cancer Drugs (Epirubicin, Cisplatin, Mitomycin C, 5-Fluorouracil) Compared with TACE with Epirubicin for Treatment of Hepatocellular Carcinoma · Shinya Sahara · 2012 · 70 citations · Cited by this paper
  28. A comparison between drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization in patients with hepatocellular carcinoma · Hongye Wang · 2020 · 56 citations · Cited by this paper
  29. China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition) · Jian Zhou · 2025 · 52 citations · Cited by this paper
  30. Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia‐inducible factor‐1α dependent pathway in hepatocellular carcinoma · Kai Qu · 2014 · 44 citations · Cited by this paper
  31. LBA2 TALENTACE: A phase III, open-label, randomized study of on-demand transarterial chemoembolization (TACE) combined with atezolizumab + bevacizumab (Atezo+Bev) or on-demand TACE alone in patients with systemically untreated, intermediate-to-high burden unresectable hepatocellular carcinoma (uHCC) · Jiahong Dong · 2025 · 44 citations · Cited by this paper
  32. Hepatic Artery Infusion Chemotherapy Using Fluorouracil, Leucovorin, and Oxaliplatin versus Transarterial Chemoembolization as Initial Treatment for Locally Advanced Hepatocellular Carcinoma: A Propensity Score–Matching Analysis · Shaolong Li · 2021 · 40 citations · Cited by this paper
  33. CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvement · Ming Dan Zhao · 2012 · 35 citations · Cited by this paper
  34. Molecular mechanisms of TACE refractoriness: Directions for improvement of the TACE procedure · Jiahao Li · 2024 · 33 citations · Cited by this paper
  35. Transarterial chemoembolization for hepatocellular carcinoma: Treatment algorithm proposed by Chinese College of Interventionalists (CCI) · Hai-Dong Zhu · 2024 · 31 citations · Cited by this paper
  36. Diameter of main tumor feeding artery of a hepatocellular carcinoma: Measurement at the entry site into the nodule · Toshiyuki Irie · 2015 · 27 citations · Cited by this paper
  37. Arterial chemoembolisation with cisplatin versus epirubicin for hepatocellular carcinoma (ACE 500 study): A multicentre, randomised controlled phase 2/3 trial · Osamu Aramaki · 2021 · 26 citations · Cited by this paper
  38. Recent highlights of cancer immunotherapy · Xianqun Fan · 2023 · 26 citations · Cited by this paper
  39. Microwave ablation vs. single-needle radiofrequency ablation for the treatment of HCC up to 4 cm: A randomized-controlled trial · Katsutoshi Sugimoto · 2024 · 26 citations · Cited by this paper

Source: OpenAlex (CC0)